Develop Your Pharmacy and Medication Strategy

A successful telehealth program depends on getting the right medications to the right patients, safely, efficiently, and consistently. And your pharmacy and medication strategy shapes every step of that process.

The decisions you make—from offering branded or compounded medications to choosing pharmacy partners and fulfillment models—can influence how quickly you launch new programs, how easily patients stay on treatment, and how your business scales over time.

A thoughtful strategy, first and foremost, supports medication fulfillment. Beyond that, it also helps operators navigate regulatory requirements, expand access across geographies, reduce operational complexity, and create a more seamless patient experience. 

When pharmacy operations run smoothly, patients are more likely to stay engaged in treatment, adhere to their care plans, and build trust in your brand. 

Here’s how to approach developing a strong pharmacy and medication strategy. 

Key Things to Consider When Developing a Pharmacy and Medication Strategy

Define Your Medication Offerings

One of the first decisions is what types of medications your program will offer. This can then influence pharmacy partnerships and fulfillment workflows as well as provider requirements, compliance, and the overall patient experience.

Many telehealth businesses build programs around categories like:

  • GLP-1s and metabolic health
  • Hormone replacement therapy (HRT/TRT)
  • Peptides and longevity
  • Prescription skincare

Each comes with different prescribing requirements, dosing considerations, monitoring needs, and fulfillment models.

From there, operators need to decide whether their programs will rely on branded medications, compounded medications, or both.

Choose Between Branded and Compounded Medications

Branded medications are FDA-approved, mass-produced drugs manufactured for specific indications. These can offer consistency and familiarity, but they may come with supply limitations, higher costs, or insurance barriers.

Compounded medications, on the other hand, are custom-prepared by licensed pharmacies to meet individual patient needs. This can include things such as alternate dosages, formulations, or ingredient adjustments. While compounded medications aren’t FDA-approved, they’re still regulated under specific pharmacy frameworks.

For many telehealth operators, the choice depends on treatment model, patient demand, and operational flexibility.

Understand 503A vs. 503B Pharmacy Models

This is one of the biggest moving parts. You’ll need to decide if you want to work with 503A or 503B pharmacies, or both, for different offerings with varying needs. Here’s an overview of how they differ: 

  • 503A pharmacies are traditional compounding pharmacies that create patient-specific medications based on an individual prescription. These are commonly used for personalized dosing or when a commercially available option isn't suitable. They’re mainly regulated by state boards of pharmacy.
  • 503B pharmacies, also called outsourcing facilities, can manufacture larger batches of compounded medications without individual patient prescriptions. These facilities are regulated by both the FDA and state boards and must follow Current Good Manufacturing Practice (cGMP) standards.

For telehealth businesses, the right model often depends on scale, speed, and the type of treatments being offered.

Plan for Mail-Order Fulfillment

Mail-order delivery has become a core part of the telehealth experience.

It expands geographic reach, supports patient convenience, and allows businesses to serve patients who may not have easy access to local pharmacies. It can also create a more consistent brand and fulfillment experience.

And remember, mail-order introduces additional considerations, including shipping timelines, temperature-sensitive medications, and tracking reliability.

Decide Whether White-Label Packaging Matters

The unboxing experience is an important thing to consider for many telehealth brands.

That’s where white-label packaging comes in. Essentially, it allows medications to arrive under your brand rather than the pharmacy partner's. This creates a more cohesive patient experience and can strengthen trust, retention, and brand recognition.

For telehealth businesses investing heavily in patient acquisition, this can be an important extension of the brand.

Vet for Compliance and Quality Standards

Pharmacy compliance should never be an afterthought. Strong compliance infrastructure protects both the business and the patient. Operators should evaluate pharmacy partners for:

  • Current Good Manufacturing Practice (cGMP) compliance 
  • DEA registration where applicable
  • State-by-state pharmacy licensing
  • Audit history
  • Quality assurance protocols
  • Controlled substance handling procedures

Think About Internally Building vs. Buying Pharmacy Operations 

Clearly, there’s a lot to consider when executing a medication and pharmacy strategy. 

Some telehealth companies choose to build their own pharmacy relationships and fulfillment systems internally. This offers greater control, but it also requires more operational overhead, compliance management, and partner coordination.

That’s why others choose to work with infrastructure partners that centralize pharmacy operations, helping them launch faster and scale more efficiently.

The right decision will come down to your internal resources, growth goals, and operational complexity. 

How CareValidate Approaches Pharmacy Strategy 

CareValidate helps operators centralize medication management and pharmacy operations in one platform, making it easier to launch, scale, and support a wide range of telehealth programs without managing multiple pharmacy relationships independently. 

Medication Capabilities

CareValidate supports many of today's fastest-growing telehealth categories, including GLP-1s, peptides, HRT, skincare, and other specialty programs.

Operators can offer access to:

  • Branded and compounded medications
  • Flexible dosing and formulations
  • Oral, topical, and injectable delivery formats
  • 503A patient-specific compounding
  • 503B outsourcing facilities for larger-scale fulfillment

This gives operators the flexibility to build medication programs around their clinical model while adapting to patient needs and market demand.

Integrated Pharmacy Infrastructure

Rather than coordinating multiple pharmacy vendors independently, CareValidate brings fulfillment into one centralized workflow.

This includes:

  • Mail-order delivery with shipment tracking
  • Nationwide pharmacy fulfillment
  • White-label packaging options
  • Automated refill reminders and reorder workflows
  • Pharmacy coordination across multiple treatment categories

Together, these capabilities help reduce operational burden while creating a more consistent patient experience.

Compliance and Quality Oversight

CareValidate works with vetted pharmacy partners that meet rigorous quality and regulatory standards, including:

  • DEA compliance
  • State pharmacy licensing
  • NABP accreditation (where applicable)
  • cGMP-compliant manufacturing
  • Ongoing quality monitoring and audit support

All of this allows telehealth brands to focus on patient growth and care delivery without building pharmacy infrastructure from scratch.

FAQs

What’s the difference between a 503A and a 503B pharmacy?
Do telehealth companies use both branded and compounded medications?
What should I look for in a pharmacy partner?